← Leaderboards

Jesse Hall

Privo Technologies, Llc

Google Scholar ↗PubMed ↗ORCID ↗

$523,684

Attributed

$1,047,367

Total exposure

1

Grants

0

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $498.4K · FY2019–21

$500K$375K$250K$125K$0

'19

'20

'21

Funding mix

By agency

FDA$1,047,367 · 1

By mechanism

R01$1,047,367 · 1

Top collaborators

Manijeh N Goldberg3 shared

Grant awards (3)

Highly focused loco-regional chemotherapy for oral cancer - IND 132234 - October 01 2017$99,660

R01 · FY2021 · FD

Highly focused loco-regional chemotherapy for oral cancer - IND 132234 - October 01 2017$498,400

R01 · FY2020 · FD

Highly focused loco-regional chemotherapy for oral cancer - IND 132234 - October 01 2017$449,307

R01 · FY2019 · FD